HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laurent Voillat Selected Research

Laurent Voillat Research Topics

Disease

17Multiple Myeloma
01/2022 - 02/2002
4Hodgkin Disease (Hodgkin's Disease)
12/2008 - 01/2002
2Neoplasms (Cancer)
03/2024 - 09/2020
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2024 - 01/2019
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2023 - 01/2019
2VEXAS syndrome
07/2023 - 11/2022
2Hemorrhage
07/2022 - 02/2006
2T-Cell Lymphoma (Lymphoma, T Cell)
01/2021 - 01/2013
2Vomiting
01/2019 - 03/2012
2Residual Neoplasm
01/2019 - 12/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
06/2020
1Autoimmune Diseases (Autoimmune Disease)
06/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2020
1Lymphopenia (Lymphocytopenia)
01/2019
1Febrile Neutropenia
01/2019
1Venous Thromboembolism
10/2013
1Disease Progression
01/2013
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2013
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2013
1Second Primary Neoplasms (Neoplasms, Second)
05/2012
1Constipation
03/2012
1Sleepiness
03/2012
1Nausea
03/2012
1Peripheral Nervous System Diseases (PNS Diseases)
03/2012
1Pathologic Complete Response
06/2006
1Infections
02/2006
1Cardiotoxicity
01/2005
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2005

Drug/Important Bio-Agent (IBA)

6Melphalan (Alkeran)FDA LinkGeneric
01/2019 - 02/2002
5Prednisone (Sone)FDA LinkGeneric
01/2019 - 02/2006
5Thalidomide (Thalomid)FDA Link
01/2017 - 11/2006
4Rituximab (Mabthera)FDA Link
11/2023 - 01/2019
3Dexamethasone (Maxidex)FDA LinkGeneric
11/2023 - 02/2006
3Bendamustine HydrochlorideFDA Link
11/2023 - 01/2013
3Bortezomib (Velcade)FDA Link
11/2023 - 01/2017
3Lenalidomide (CC 5013)FDA Link
01/2021 - 05/2012
2Proteins (Proteins, Gene)FDA Link
03/2024 - 12/2016
2EnzymesIBA
07/2023 - 01/2019
2carfilzomibIBA
01/2022 - 01/2019
2Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 06/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 06/2006
2N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
06/2006 - 01/2002
1ibrutinibIBA
03/2024
1UbiquitinIBA
07/2023
1Azacitidine (5 Azacytidine)FDA Link
11/2022
1SteroidsIBA
11/2022
1AnticoagulantsIBA
07/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
06/2020
1Inosine Triphosphate (ITP)IBA
06/2020
1AutoantibodiesIBA
06/2020
1AntibodiesIBA
06/2020
1Platelet Membrane GlycoproteinsIBA
06/2020
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2019
1Immunomodulating AgentsIBA
10/2013
1Interleukin-6 (Interleukin 6)IBA
05/2007
1Type II Tumor Necrosis Factor ReceptorsIBA
05/2007
1Interleukin-10 (Interleukin 10)IBA
05/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2007
1CytokinesIBA
05/2007
1Procarbazine (Matulane)FDA Link
06/2006
1Vinblastine (Vinblastine Sulfate)FDA Link
06/2006
1Mechlorethamine (Nitrogen Mustard)FDA Link
06/2006
1Bleomycin (Blenoxane)FDA LinkGeneric
06/2006
1AnthracyclinesIBA
01/2005

Therapy/Procedure

10Therapeutics
07/2022 - 01/2002
10Stem Cell Transplantation
04/2020 - 01/2002
6Drug Therapy (Chemotherapy)
04/2020 - 01/2002
2Salvage Therapy
12/2008 - 01/2002
1Transplantation
05/2012
1Combination Drug Therapy (Combination Chemotherapy)
10/2007
1Consolidation Chemotherapy
06/2006
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2002